PLUS1
31.99
0.16 (0.5%)
0.16 (0.5%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arcutis Biotherapeutics Inc | ARQT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.16 | 0.5% | 31.99 | 31.00 | 32.3275 | 31.85 | 31.83 | 12:24:05 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 31.57 | 32.04 | 0.47 | 1.47% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 197 | 13,484 | $ 31.81 | $ 428,886 | 105,581 | 17.10 - 40.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:26:18 | 100 | $ 31.99 | USD |
Arcutis Biotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.22B | 38.15M | 17.97M | $ - | $ - | -1.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 20.00 | 5.20% |
Arcutis Biotherapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/22/2020 | 09:00 | GlobeNewswire Inc. | Arcutis Enrolls Last Patient in Phase 2 Proof of Concept.. |
| 6/15/2020 | 15:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/10/2020 | 16:05 | GlobeNewswire Inc. | Arcutis to Present at the Goldman Sachs 41st Annual Global.. |
| 6/01/2020 | 09:00 | GlobeNewswire Inc. | Ayisha Jeter Joins Arcutis as Vice President of Market.. |
| 5/27/2020 | 09:00 | GlobeNewswire Inc. | Jay Ramsinghani Joins Arcutis as Vice President of.. |
| 5/13/2020 | 16:36 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/12/2020 | 16:33 | Edgar (US Regulatory) | Quarterly Report (10-q) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARQT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 32.13 | 34.475 | 29.17 | 31.96 | 81,508 | -0.14 | -0.44% |
| 1 Month | 33.02 | 39.8527 | 25.00 | 31.18 | 112,874 | -1.03 | -3.12% |
| 3 Months | 27.69 | 39.8527 | 23.22 | 29.99 | 80,178 | 4.30 | 15.53% |
| 6 Months | 23.05 | 40.88 | 17.10 | 27.89 | 143,545 | 8.94 | 38.79% |
| 1 Year | 23.05 | 40.88 | 17.10 | 27.89 | 143,545 | 8.94 | 38.79% |
| 3 Years | 23.05 | 40.88 | 17.10 | 27.89 | 143,545 | 8.94 | 38.79% |
| 5 Years | 23.05 | 40.88 | 17.10 | 27.89 | 143,545 | 8.94 | 38.79% |
Arcutis Biotherapeutics Description
| Arcutis Biotherapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. The company targets immune-mediated dermatological diseases and conditions, or immuno-dermatology. |
